132 related articles for article (PubMed ID: 35090987)
1. The double anaerobic threshold in heart failure.
Rovai S; Contini M; Sciomer S; Vignati C; Agostoni P
Int J Cardiol; 2022 Apr; 353():68-70. PubMed ID: 35090987
[TBL] [Abstract][Full Text] [Related]
2. Effects of beta-blockers on ventilation efficiency in heart failure.
Agostoni P; Apostolo A; Cattadori G; Salvioni E; Berna G; Antonioli L; Vignati C; Schina M; Sciomer S; Bussotti M; Palermo P; Fiorentini C; Contini M
Am Heart J; 2010 Jun; 159(6):1067-73. PubMed ID: 20569721
[TBL] [Abstract][Full Text] [Related]
3. Multiparametric comparison of CARvedilol, vs. NEbivolol, vs. BIsoprolol in moderate heart failure: the CARNEBI trial.
Contini M; Apostolo A; Cattadori G; Paolillo S; Iorio A; Bertella E; Salvioni E; Alimento M; Farina S; Palermo P; Loguercio M; Mantegazza V; Karsten M; Sciomer S; Magrì D; Fiorentini C; Agostoni P
Int J Cardiol; 2013 Oct; 168(3):2134-40. PubMed ID: 23506636
[TBL] [Abstract][Full Text] [Related]
4. Lung function with carvedilol and bisoprolol in chronic heart failure: is beta selectivity relevant?
Agostoni P; Contini M; Cattadori G; Apostolo A; Sciomer S; Bussotti M; Palermo P; Fiorentini C
Eur J Heart Fail; 2007 Aug; 9(8):827-33. PubMed ID: 17561440
[TBL] [Abstract][Full Text] [Related]
5. The double anaerobic threshold in heart failure: MECKI score database overview.
Rovai S; Zaffalon D; Cittar M; Felli LF; Salvioni E; Galotta A; Mattavelli I; Carriere C; Mapelli M; Merlo M; Vignati C; Sinagra G; Agostoni P
ESC Heart Fail; 2022 Aug; 9(4):2119-2124. PubMed ID: 35579114
[TBL] [Abstract][Full Text] [Related]
6. Differences between beta-blockers in patients with chronic heart failure and chronic obstructive pulmonary disease: a randomized crossover trial.
Jabbour A; Macdonald PS; Keogh AM; Kotlyar E; Mellemkjaer S; Coleman CF; Elsik M; Krum H; Hayward CS
J Am Coll Cardiol; 2010 Apr; 55(17):1780-7. PubMed ID: 20413026
[TBL] [Abstract][Full Text] [Related]
7. Evidence of a double anaerobic threshold in healthy subjects.
Rovai S; Magini A; Cittar M; Masè M; Carriere C; Contini M; Vignati C; Sinagra G; Agostoni P
Eur J Prev Cardiol; 2022 Mar; 29(3):502-509. PubMed ID: 34160034
[TBL] [Abstract][Full Text] [Related]
8. [Assessment of the efficacy of bisoprolol administration by cardiopulmonary exercise testing in patients with heart failure].
Terzi S; Dayi SU; Akbulut T; Dağ O; Köse H; Satiroğlu O; Sayar N; Bilsel T; Aksoy S; Yeşilçimen K
Anadolu Kardiyol Derg; 2003 Dec; 3(4):313-8. PubMed ID: 14675880
[TBL] [Abstract][Full Text] [Related]
9. Effects of carvedilol vs bisoprolol on inflammation and oxidative stress in patients with chronic heart failure.
Toyoda S; Haruyama A; Inami S; Arikawa T; Saito F; Watanabe R; Sakuma M; Abe S; Nakajima T; Tanaka A; Node K; Inoue T
J Cardiol; 2020 Feb; 75(2):140-147. PubMed ID: 31444140
[TBL] [Abstract][Full Text] [Related]
10. The Effect of beta-blockade on objectively measured physical fitness in patients with abdominal aortic aneurysms--A blinded interventional study.
West MA; Parry M; Asher R; Key A; Walker P; Loughney L; Pintus S; Duffy N; Jack S; Torella F
Br J Anaesth; 2015 Jun; 114(6):878-85. PubMed ID: 25716221
[TBL] [Abstract][Full Text] [Related]
11. Comparative effects of carvedilol vs bisoprolol for severe congestive heart failure.
Konishi M; Haraguchi G; Kimura S; Inagaki H; Kawabata M; Hachiya H; Hirao K; Isobe M
Circ J; 2010 Jun; 74(6):1127-34. PubMed ID: 20354334
[TBL] [Abstract][Full Text] [Related]
12. Older adults with heart failure treated with carvedilol, bisoprolol, or metoprolol tartrate: risk of mortality.
Perreault S; de Denus S; White M; White-Guay B; Bouvier M; Dorais M; Dubé MP; Rouleau JL; Tardif JC; Jenna S; Haibe-Kains B; Leduc R; Deblois D
Pharmacoepidemiol Drug Saf; 2017 Jan; 26(1):81-90. PubMed ID: 27859924
[TBL] [Abstract][Full Text] [Related]
13. The mortality benefit of carvedilol versus bisoprolol in patients with heart failure with reduced ejection fraction.
Choi KH; Lee GY; Choi JO; Jeon ES; Lee HY; Lee SE; Kim JJ; Chae SC; Baek SH; Kang SM; Choi DJ; Yoo BS; Kim KH; Cho MC; Park HY; Oh BH
Korean J Intern Med; 2019 Sep; 34(5):1030-1039. PubMed ID: 30317846
[TBL] [Abstract][Full Text] [Related]
14. Effects of β
Contini M; Spadafora E; Barbieri S; Gugliandolo P; Salvioni E; Magini A; Apostolo A; Palermo P; Alimento M; Agostoni P
Sci Rep; 2020 Apr; 10(1):7101. PubMed ID: 32345990
[TBL] [Abstract][Full Text] [Related]
15. Titration to target dose of bisoprolol vs. carvedilol in elderly patients with heart failure: the CIBIS-ELD trial.
Düngen HD; Apostolovic S; Inkrot S; Tahirovic E; Töpper A; Mehrhof F; Prettin C; Putnikovic B; Neskovic AN; Krotin M; Sakac D; Lainscak M; Edelmann F; Wachter R; Rau T; Eschenhagen T; Doehner W; Anker SD; Waagstein F; Herrmann-Lingen C; Gelbrich G; Dietz R;
Eur J Heart Fail; 2011 Jun; 13(6):670-80. PubMed ID: 21429992
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of bisoprolol fumarate compared with carvedilol in Japanese patients with chronic heart failure: results of the randomized, controlled, double-blind, Multistep Administration of bisoprolol IN Chronic Heart Failure II (MAIN-CHF II) study.
Hori M; Nagai R; Izumi T; Matsuzaki M
Heart Vessels; 2014 Mar; 29(2):238-47. PubMed ID: 23559359
[TBL] [Abstract][Full Text] [Related]
17. Relationship between heart failure, concurrent chronic obstructive pulmonary disease and beta-blocker use: a Danish nationwide cohort study.
Sessa M; Mascolo A; Mortensen RN; Andersen MP; Rosano GMC; Capuano A; Rossi F; Gislason G; Enghusen-Poulsen H; Torp-Pedersen C
Eur J Heart Fail; 2018 Mar; 20(3):548-556. PubMed ID: 29159953
[TBL] [Abstract][Full Text] [Related]
18. Tolerability, Efficacy, and Safety of Bisoprolol vs. Carvedilol in Japanese Patients With Heart Failure and Reduced Ejection Fraction - The CIBIS-J Trial.
Tsutsui H; Momomura SI; Masuyama T; Saito Y; Komuro I; Murohara T; Kinugawa S;
Circ J; 2019 May; 83(6):1269-1277. PubMed ID: 30956267
[TBL] [Abstract][Full Text] [Related]
19. A cutoff point for peak oxygen consumption in the prognosis of heart failure patients with β-blocker therapy.
Guimaraes GV; d'Avila VM; Silva MS; Ferreira SA; Ciolac EG; Carvalho VO; Bocchi EA
Int J Cardiol; 2010 Nov; 145(1):75-7. PubMed ID: 19477026
[TBL] [Abstract][Full Text] [Related]
20. Effect of carvedilol on heart rate response to cardiopulmonary exercise up to the anaerobic threshold in patients with subacute myocardial infarction.
Nemoto S; Kasahara Y; Izawa KP; Watanabe S; Yoshizawa K; Takeichi N; Kamiya K; Suzuki N; Omiya K; Matsunaga A; Akashi YJ
Heart Vessels; 2019 Jun; 34(6):957-964. PubMed ID: 30604188
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
